InvestSMART

NeuroScientific Biopharmaceuticals Ltd (ASX: NSB) - Announcements

Current share price for NSB : $0.060 0.001 (1.64%)+

ASX company news and announcements for NeuroScientific Biopharmaceuticals Ltd (NSB) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All NeuroScientific Biopharmaceuticals Ltd (NSB) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than NeuroScientific Biopharmaceuticals Ltd (NSB), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for NeuroScientific Biopharmaceuticals Ltd (NSB)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$23 Quarterly Activities/Appendix 4C Cash Flow Report 31 Jan 2022 5:28PM $0.290 $0.060 fallen by 79.31%
$23 Positive off-target safety assessment of EmtinB 24 Dec 2021 8:22AM $0.305 $0.060 fallen by 80.33%
$23 Positive results in biomarker characterisation of Emtins 21 Dec 2021 9:57AM $0.305 $0.060 fallen by 80.33%
$23 Change of Registry Address 20 Dec 2021 2:56PM $0.305 $0.060 fallen by 80.33%
$23 Change of Director's Interest Notice 13 Dec 2021 7:10PM $0.320 $0.060 fallen by 81.25%
$23 Change of Director's Interest Notice 13 Dec 2021 7:09PM $0.320 $0.060 fallen by 81.25%
$23 Change of Director's Interest Notice 13 Dec 2021 7:09PM $0.320 $0.060 fallen by 81.25%
$23 Change of Director's Interest Notice 13 Dec 2021 7:07PM $0.320 $0.060 fallen by 81.25%
$23 Notification regarding unquoted securities - NSB 8 Dec 2021 3:10PM $0.325 $0.060 fallen by 81.54%
$23 Notification regarding unquoted securities - NSB 8 Dec 2021 3:00PM $0.325 $0.060 fallen by 81.54%
$23 Investor Webinar Presentation 3 Dec 2021 8:19AM $0.330 $0.060 fallen by 81.82%
$23 NSB partners with leading diffusion MRI company Imeka 22 Nov 2021 8:24AM $0.355 $0.060 fallen by 83.10%
$23 Investor Webinar Presentation 18 Nov 2021 10:17AM $0.360 $0.060 fallen by 83.33%
$23 Adoption of New Constitution 11 Nov 2021 5:32PM $0.350 $0.060 fallen by 82.86%
$23 Results of Meeting 11 Nov 2021 4:59PM $0.350 $0.060 fallen by 82.86%
$23 Chairman's Address to Shareholders 11 Nov 2021 12:56PM $0.330 $0.060 fallen by 81.82%
$23 NSB Partners with Biospective for MS Studies 2 Nov 2021 8:39AM $0.340 $0.060 fallen by 82.35%
$23 Quarterly Activities/Appendix 4C Cash Flow Report 29 Oct 2021 6:38PM $0.360 $0.060 fallen by 83.33%
$23 Company Presentation - updated 26 Oct 2021 5:49PM $0.380 $0.060 fallen by 84.21%
$23 Company Presentation 26 Oct 2021 2:03PM $0.400 $0.060 fallen by 85%
$23 Completion of Safety Pharmacology Studies 18 Oct 2021 9:42AM $0.400 $0.060 fallen by 85%
$23 Proposed issue of securities - NSB 11 Oct 2021 2:53PM $0.400 $0.060 fallen by 85%
$23 Notice of Annual General Meeting/Proxy Form 11 Oct 2021 2:46PM $0.400 $0.060 fallen by 85%
$23 Appendix 4G 23 Sep 2021 4:45PM $0.440 $0.060 fallen by 86.36%
$23 Corporate Governance Statement 23 Sep 2021 4:45PM $0.440 $0.060 fallen by 86.36%

176 - 200 of 407 results

Page 8 of 17

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.